These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6204603)

  • 41. [Use of beta-adrenoblockaders in the therapy of the syndromes accompanying acute myocardial infarct].
    Golikov AP; Vaniev SB; Berestov AA; Maĭorov NI; Orlov AI
    Kardiologiia; 1981 Dec; 21(12):60-4. PubMed ID: 6120256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Benefit of beta-blockers after myocardial infarction.
    Owen A
    Lancet; 2001 Oct; 358(9291):1457-8. PubMed ID: 11705520
    [No Abstract]   [Full Text] [Related]  

  • 43. Beta blocking agents in post myocardial infarction patients.
    Campbell RW; Bourke J
    Eur Heart J; 1986 May; 7 Suppl A():119-21. PubMed ID: 2873038
    [No Abstract]   [Full Text] [Related]  

  • 44. [Beta-blocker therapy in the management of malignant ventricular arrhythmia in patients with acute myocardial infarction].
    Ma HL; Fang YM; Ma YL; Feng J; Wang KQ; Ge JB
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Apr; 24(4):475-6. PubMed ID: 15090331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early use of beta-adrenergic-blocking agents in acute myocardial infarction.
    Mauro VF; Zeller FP
    Drug Intell Clin Pharm; 1986 Jan; 20(1):14-9. PubMed ID: 2867883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effects of beta blockers on the parameters of acute phase response and level of circulating immune complexes in myocardial infarct].
    Korochkin IM; Chukaeva II; Aleshkin AV; Smolina NV; Litvinova SN; Aleksandrov AA
    Sov Med; 1991; (6):45-7. PubMed ID: 1716007
    [No Abstract]   [Full Text] [Related]  

  • 48. [Variability of heart rate in postmyocardial infarction patients: clinical implications, problems and prospects].
    Popov VV; Kopitsa NP; Oparin AL
    Klin Med (Mosk); 1998; 76(2):15-9. PubMed ID: 9553353
    [No Abstract]   [Full Text] [Related]  

  • 49. Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials.
    Cucherat M
    Eur Heart J; 2007 Dec; 28(24):3012-9. PubMed ID: 17981830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Drugs and the heart].
    Cullhed I; Aberg H
    Lakartidningen; 1976 Sep; 73(36):2880-1. PubMed ID: 9539
    [No Abstract]   [Full Text] [Related]  

  • 51. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can beta blockers limit myocardial infarct size?
    Hearse DJ; Yellon DM; Downey JM
    Eur Heart J; 1986 Nov; 7(11):925-30. PubMed ID: 2878807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta-adrenoceptor blocking drugs and acute myocardial infarction.
    Singh BN
    Drugs; 1978 Mar; 15(3):218-25. PubMed ID: 25168
    [No Abstract]   [Full Text] [Related]  

  • 54. [Adren beta recept block and extension of infarction].
    Kupper W; Bleifeld W
    Dtsch Med Wochenschr; 1980 Apr; 105(14):457-60. PubMed ID: 6153955
    [No Abstract]   [Full Text] [Related]  

  • 55. [Diagnostic and therapeutic strategies in post-infarct].
    Romano S; Rinaldi E; Fusilli C; Celotto A; Scrimieri P; Penco M
    Clin Ter; 2000; 151(1):37-43. PubMed ID: 10822880
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The effect of a combination ACE inhibitor and beta-blockers in acute myocardial infarct].
    Di Pasquale P; Paterna S
    G Ital Cardiol; 1999 Aug; 29(8):938-42. PubMed ID: 10488458
    [No Abstract]   [Full Text] [Related]  

  • 57. [Behavior of ventricular ectopia in the acute phase of infarction with and without nifedipine (Adalat)].
    Beck OA; Geisler S; Hochrein H
    MMW Munch Med Wochenschr; 1983 Sep; 125(38):825-6. PubMed ID: 6195523
    [No Abstract]   [Full Text] [Related]  

  • 58. [The use of other drugs apart from antithrombotic and antiplatelet agents for the treatment of non-ST-elevation acute coronary syndromes].
    Birdane A; Ata N
    Anadolu Kardiyol Derg; 2006 Apr; 6 Suppl 1():30-4. PubMed ID: 16613773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Secondary prevention after an acute myocardial infarct. Adrenergic beta-blockers, angiotensin-converting enzyme inhibitors and statins for everyone?].
    Morais J
    Rev Port Cardiol; 2000 Jan; 19(1):99-105. PubMed ID: 10731795
    [No Abstract]   [Full Text] [Related]  

  • 60. Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction.
    Halkin A; Grines CL; Cox DA; Garcia E; Mehran R; Tcheng JE; Griffin JJ; Guagliumi G; Brodie B; Turco M; Rutherford BD; Aymong E; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2004 May; 43(10):1780-7. PubMed ID: 15145099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.